Steris Plc (STE31) Return on Equity ROE from the first quarter 2026 to first quarter 2022 and annually, average high and low, overall ranking from Jun 30 2026 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Steris Plc  (NYSE: STE31)

Steris Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Steris Plc in the first quarter 2026?
Steris Plc achieved a return on average equity (ROE) of 1.84 % in its first quarter 2026, which is below Steris Plc's average return on equity, which stands at 7.32%.

ROE has advanced compared to -0.46% in the third quarter 2023, due to net income growth.

Within the Medical Equipment & Supplies industry 66 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2023 from to 2720.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
I. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Equity Change 10.34 % 68.18 % -11.18 % -2.52 % -
Y / Y Net Income Change 286.14 % -13.82 % - - -40.95 %
Net Income (TTM) in Millions 120 -29 -9 376 243
Return On Equity (TTM) 1.84 % -0.46 % -0.16 % 6.42 % 4.12 %
STE31's Total Ranking # 2720 # # # #
Equity (TTM) in Millions 7,221 6,545 5,813 6,419 6,545
Seq. Equity Change 10.34 % 12.58 % -9.44 % -1.92 % 68.18 %
Seq. Net Income Change 62.98 % - - 112.77 % -63.62 %

Back to STE31 Management Effectiveness >> STE31's 5 Years Annual ROE >> Compare STE31 ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 67
Sector # 215
Overall # 2720

Return On Equity Statistics
High Average Low
12.45 %
7.32 %
-0.46 %
(Mar 31 2020)   (Dec 31 2022)





STE31 Annual Return On Equity (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2017)
2019
Total Equity in Millions 6,545 3,891 3,407 3,217 0
Y / Y Equity Change 68.18 % 14.23 % 5.89 % - -
Net Income in Millions 243 397 408 111 0
Y / Y Net Income Change -38.8 % -2.68 % 268.62 % - -
Return On Equity 3.71 % 10.2 % 11.97 % 3.44 % -

Back to STE31 Management Effectiveness >> STE31's 5 Years Annual ROE >> Compare STE31 ROE to its Competitors




Annual Roe Comment
In 2022 ROE decreased compared to the previous year to 3.71 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
STE31's' Return on Equity at Yahoo Finance
STE31's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for STE31's Competitors
Subscribers only: Roe for Steris Plc's Suppliers
Subscribers only: Return On Equity for STE31's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Pfizer Inc  4.91 %
Privia Health Group Inc   4.23 %
Becton Dickinson And Company  3.79 %
Alkermes Plc   3.72 %
Lifemd Inc   3.47 %
Lifestance Health Group Inc   3.39 %
Revvity Inc  3.27 %
Bio rad Laboratories Inc   3.15 %
Envista Holdings Corporation  3.08 %
Immucell Corporation  2.68 %
Surgery Partners Inc   2.63 %
Mimedx Group Inc   2.61 %
Cormedix Inc   2.18 %
Atricure Inc   2.14 %
Pacira Biosciences inc   2.13 %
Warby Parker Inc   2.06 %
Repligen Corp  1.98 %
Arvinas Inc   1.91 %
Waters Corporation  1.88 %
Omada Health Inc   1.84 %
Radnet Inc   1.42 %
Icu Medical Inc  1.41 %
Biomarin Pharmaceutical Inc  1.18 %
Staar Surgical Co  1.08 %
Champions Oncology Inc   0.94 %
Delcath Systems Inc   0.46 %

Date modified: 2026-09-12T06:23:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.